glp 1 liver Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty disease (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism Simplified summary of the biological

J.ChenY.LinJ

Impacts of Lifestyle and Microbiota-Targeted Interventions for Overweight and Obesity on the Human Gut Microbiome: A Systematic Review

It is one of the most prescribed medications worldwide for blood sugar management, primarily because of its affordability, long track record of success, and relatively low risk of side effects

More recent agents include dual agonists such as tirzepatide, which activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors and produces even greater weight loss

Effects of vildagliptin on ventricular function in patients with type 2 diabetes mellitus and heart failure: a randomized placebo-controlled trial

Further clinical evidence also indicates that long-term therapy with exenatide may offer some degree of pancreatic -cell protection, an important consideration in slowing disease progression